Difference between revisions of "Quick Reference"

(Commonly available drainage catheter types)
(Commonly available drainage catheter types)
Line 38: Line 38:
 
|}
 
|}
  
== Commonly available drainage catheter types ==
+
== Drainage catheter types ==
 
{| class="wikitable"
 
{| class="wikitable"
 
|+
 
|+
 
!
 
!
!~8 Fr
+
!~8.5 Fr
!~10 Fr
+
!~10.2 Fr
 
!12 Fr
 
!12 Fr
 
!14 Fr
 
!14 Fr
 
!16 Fr
 
!16 Fr
!18 Fr
 
 
!20 Fr
 
!20 Fr
 
!24 Fr
 
!24 Fr
Line 58: Line 57:
 
|25 cm
 
|25 cm
 
|25 cm
 
|25 cm
| -
 
 
| -
 
| -
 
| -
 
| -
Line 74: Line 72:
 
|25,45 cm
 
|25,45 cm
 
|25 cm
 
|25 cm
| -
 
 
| -
 
| -
 
| -
 
| -
Line 87: Line 84:
 
|50cm
 
|50cm
 
|50cm
 
|50cm
| -
 
 
| -
 
| -
 
| -
 
| -
Line 101: Line 97:
 
| -
 
| -
 
|45 cm
 
|45 cm
| -
 
 
| -
 
| -
 
| -
 
| -
Line 116: Line 111:
 
| -
 
| -
 
|40 cm
 
|40 cm
| -
 
 
| -
 
| -
 
| -
 
| -
Line 130: Line 124:
 
| -
 
| -
 
|41 cm
 
|41 cm
| -
 
 
|41 cm
 
|41 cm
 
|41 cm
 
|41 cm
Line 137: Line 130:
 
Nonrestrictive drainage connection (Foley bag)
 
Nonrestrictive drainage connection (Foley bag)
 
|-
 
|-
|Uresil
+
|Uresil (UIti-Flo general purpose catheter)
| -
 
 
| -
 
| -
 
| -
 
| -
Line 148: Line 140:
 
|41 cm
 
|41 cm
 
|Nonrestrictive drainage connection (Foley bag)
 
|Nonrestrictive drainage connection (Foley bag)
|-
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
 
|}
 
|}
 +
8 Fr and 10 Fr catheters may come in slightly different sizes. Other diameters may be available pending availability.
  
 
== Periprocedural management of coagulation status==
 
== Periprocedural management of coagulation status==

Revision as of 07:50, 13 February 2019

Non-per-oral

NPO Time:[1]
Minimum fasting period
Clear liquids 2h
Breast milk 4h
Infant formula, nonhuman milk, light meal 6h
Fried foods, fatty foods, or meat Potentially 8+hours needed

Central venous catheter types

Central venous catheter types:
Non-Tunneled Tunneled
General access Hohn +/- power injectable (brochure, IFU) Hickman (brochure, IFU)
Pheresis Hemocath ST (brochure, IFU) Trifusion (brochure, IFU)
Dialysis Trialysis (brochure, IFU) Duraflow (brochure, IFU)

Drainage catheter types

~8.5 Fr ~10.2 Fr 12 Fr 14 Fr 16 Fr 20 Fr 24 Fr 28 Fr Practical considerations
Dawson-Mueller Multipurpose Drainage (DM) 25 cm 25 cm 25 cm 25 cm - - - - 5 side ports

10mm loop diameter

Small cavity sizes

Cope Loop (aka Mac-Loc Multipurpose Drainage) 25 cm 25,45 cm 25,45 cm 25,45 cm 25 cm - - - 6 side ports

25mm loop diameter

Standard cavity sizes

Ring biliary drain - 50cm 50cm - - - - - Multiple side ports along 25 cm
Amplatz Universal Drain (AUD) - 45 cm 45 cm - 45 cm - - - 6 side ports

Non-locking pigtail

Potentially less encrustation (no pigtail string)

Gordon Large-bore - - - - 40 cm - - - Easy to cut proximal side-holes

Nonrestrictive drainage connection (Foley bag)

Thal-quick abscess drainage - - - - 41 cm 41 cm 41 cm - 3 oval Sideports

Nonrestrictive drainage connection (Foley bag)

Uresil (UIti-Flo general purpose catheter) - - - - - 41 cm 41 cm 41 cm Nonrestrictive drainage connection (Foley bag)

8 Fr and 10 Fr catheters may come in slightly different sizes. Other diameters may be available pending availability.

Periprocedural management of coagulation status

Periprocedural management of coagulation status[2][3]
Category 1:

Low risk of bleeding, easily detected and controlled

Category 2:

Moderate risk of bleeding

Category 3:

Significant bleeding risk, difficult to detect or control

PT-INR >2.0 threshold for treatment Correct to <1.5 Correct to <1.5
PTT No consensus No consensus, but consider correcting for PTT > 1.5x control Stop or reverse heparin for PTT > 1.5x control
Platelets <50k/uL: transfuse <50k/uL: transfuse <50k/uL: transfuse
Clopidogrel and Prasugrel

Ticlodipine

Hold 5 days

Hold 5 days

Hold 5 days

Hold 7 days

Hold 5 days

Hold 7 days

Aspirin Do not hold Do not hold Hold 5 days
LMWH Hold 1 dose before procedure Hold 1 dose before procedure Hold 24h or up to 2 doses
Short-acting (ibuprofen, indomethacin)

Intermediate-acting (Naproxen, celecoxib)

Long acting (meloxicam)

Do not hold

Do not hold

Do not hold

Do not hold

Do not hold

Do not hold

Hold 1d

Hold 2-3d

Hold 10d

NOACs Do not hold 5 half lives? 5 half lives?

Cat 1 procedures include:

  • Vascular: Dialysis access interventions Venography, Central line removal, IVC filter placement, PICC placement
  • Nonvascular: Drainage catheter exchange (biliary, nephrostomy, abscess catheter) Thoracentesis Paracentesis Superficial aspiration and biopsy (excludes intrathoracic or intraabdominal sites): thyroid, superficial lymph node Superficial abscess drainage

Cat 2 procedures include:

  • Vascular - Angiography, arterial intervention with access size up to 7 F Venous interventions, Chemoembolization, Uterine fibroid embolization, Transjugular liver biopsy, Tunneled central venous catheter Subcutaneous port device
  • Nonvascular- Intraabdominal, chest wall, or retroperitoneal abscess drainage or biopsy, Lung biopsy, Transabdominal liver biopsy (core needle), Percutaneous cholecystostomy, Gastrostomy tube: initial placement, Radiofrequency ablation: straightforward Spine procedures (vertebroplasty, kyphoplasty, lumbar puncture, epidural injection, facet block)

Cat 3 procedures include:

  • Vascular - TIPS
  • Nonvascular - Renal biopsy, Biliary interventions (new tract), Nephrostomy tube placement, Radiofrequency ablation: complex
  1. Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration. Anesthesiology. 2017;126(3):376-393.http://anesthesiology.pubs.asahq.org/article.aspx?articleid=2596245
  2. Patel IJ, Davidson JC, Nikolic B, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727-36. https://www.jvir.org/article/S1051-0443(12)00297-7/pdf
  3. Patel IJ, Davidson JC, Nikolic B, et al. Addendum of newer anticoagulants to the SIR consensus guideline. J Vasc Interv Radiol. 2013;24(5):641-5. https://www.jvir.org/article/S1051-0443(12)01238-9/pdf

Contributing Authors

BGG, Kevin Liu